aluates Reports

$ 0.0

Automative

Global Irritable Bowel Syndrome Drug Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-4R15693

Global Irritable Bowel Syndrome Drug Market Research Report 2023

BUY CHAPTERS

Global Irritable Bowel Syndrome Drug Market Research Report 2024

Code: QYRE-Auto-4R15693

Report

August 2024

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ironwood Pharmaceuticals

Bausch Health

Takeda

Sebela Pharmaceuticals

Irritable Bowel Syndrome Drug Market

The global Irritable Bowel Syndrome Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Irritable Bowel Syndrome Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Irritable Bowel Syndrome Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Irritable Bowel Syndrome Drug in Women is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Irritable Bowel Syndrome Drug include Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals and Allergan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome Drug.

Report Scope

The Irritable Bowel Syndrome Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irritable Bowel Syndrome Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Irritable Bowel Syndrome Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Irritable Bowel Syndrome Drug Market Report

Report Metric	Details
Report Name	Irritable Bowel Syndrome Drug Market
Segment by Type	IBS-D Drugs IBS-C Drugs Others
Segment by Application	Women Men
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Irritable Bowel Syndrome Drug Market report?

Ans: The main players in the Irritable Bowel Syndrome Drug Market are Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals, Allergan

What are the Application segmentation covered in the Irritable Bowel Syndrome Drug Market report?

Ans: The Applications covered in the Irritable Bowel Syndrome Drug Market report are Women, Men

What are the Type segmentation covered in the Irritable Bowel Syndrome Drug Market report?

Ans: The Types covered in the Irritable Bowel Syndrome Drug Market report are IBS-D Drugs, IBS-C Drugs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 IBS-D Drugs

1.2.3 IBS-C Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Irritable Bowel Syndrome Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Women

1.3.3 Men

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Irritable Bowel Syndrome Drug Market Perspective (2019-2030)

2.2 Irritable Bowel Syndrome Drug Growth Trends by Region

2.2.1 Global Irritable Bowel Syndrome Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Irritable Bowel Syndrome Drug Historic Market Size by Region (2019-2024)

2.2.3 Irritable Bowel Syndrome Drug Forecasted Market Size by Region (2025-2030)

2.3 Irritable Bowel Syndrome Drug Market Dynamics

2.3.1 Irritable Bowel Syndrome Drug Industry Trends

2.3.2 Irritable Bowel Syndrome Drug Market Drivers

2.3.3 Irritable Bowel Syndrome Drug Market Challenges

2.3.4 Irritable Bowel Syndrome Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Irritable Bowel Syndrome Drug Players by Revenue

3.1.1 Global Top Irritable Bowel Syndrome Drug Players by Revenue (2019-2024)

3.1.2 Global Irritable Bowel Syndrome Drug Revenue Market Share by Players (2019-2024)

3.2 Global Irritable Bowel Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Irritable Bowel Syndrome Drug Revenue

3.4 Global Irritable Bowel Syndrome Drug Market Concentration Ratio

3.4.1 Global Irritable Bowel Syndrome Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome Drug Revenue in 2023

3.5 Irritable Bowel Syndrome Drug Key Players Head office and Area Served

3.6 Key Players Irritable Bowel Syndrome Drug Product Solution and Service

3.7 Date of Enter into Irritable Bowel Syndrome Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Irritable Bowel Syndrome Drug Breakdown Data by Type

4.1 Global Irritable Bowel Syndrome Drug Historic Market Size by Type (2019-2024)

4.2 Global Irritable Bowel Syndrome Drug Forecasted Market Size by Type (2025-2030)

5 Irritable Bowel Syndrome Drug Breakdown Data by Application

5.1 Global Irritable Bowel Syndrome Drug Historic Market Size by Application (2019-2024)

5.2 Global Irritable Bowel Syndrome Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Irritable Bowel Syndrome Drug Market Size (2019-2030)

6.2 North America Irritable Bowel Syndrome Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Irritable Bowel Syndrome Drug Market Size by Country (2019-2024)

6.4 North America Irritable Bowel Syndrome Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Irritable Bowel Syndrome Drug Market Size (2019-2030)

7.2 Europe Irritable Bowel Syndrome Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Irritable Bowel Syndrome Drug Market Size by Country (2019-2024)

7.4 Europe Irritable Bowel Syndrome Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Irritable Bowel Syndrome Drug Market Size (2019-2030)

8.2 Asia-Pacific Irritable Bowel Syndrome Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Irritable Bowel Syndrome Drug Market Size (2019-2030)

9.2 Latin America Irritable Bowel Syndrome Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Irritable Bowel Syndrome Drug Market Size by Country (2019-2024)

9.4 Latin America Irritable Bowel Syndrome Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Irritable Bowel Syndrome Drug Market Size (2019-2030)

10.2 Middle East & Africa Irritable Bowel Syndrome Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ironwood Pharmaceuticals

11.1.1 Ironwood Pharmaceuticals Company Detail

11.1.2 Ironwood Pharmaceuticals Business Overview

11.1.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Introduction

11.1.4 Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2019-2024)

11.1.5 Ironwood Pharmaceuticals Recent Development

11.2 Bausch Health

11.2.1 Bausch Health Company Detail

11.2.2 Bausch Health Business Overview

11.2.3 Bausch Health Irritable Bowel Syndrome Drug Introduction

11.2.4 Bausch Health Revenue in Irritable Bowel Syndrome Drug Business (2019-2024)

11.2.5 Bausch Health Recent Development

11.3 Takeda

11.3.1 Takeda Company Detail

11.3.2 Takeda Business Overview

11.3.3 Takeda Irritable Bowel Syndrome Drug Introduction

11.3.4 Takeda Revenue in Irritable Bowel Syndrome Drug Business (2019-2024)

11.3.5 Takeda Recent Development

11.4 Sebela Pharmaceuticals

11.4.1 Sebela Pharmaceuticals Company Detail

11.4.2 Sebela Pharmaceuticals Business Overview

11.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Introduction

11.4.4 Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2019-2024)

11.4.5 Sebela Pharmaceuticals Recent Development

11.5 Allergan

11.5.1 Allergan Company Detail

11.5.2 Allergan Business Overview

11.5.3 Allergan Irritable Bowel Syndrome Drug Introduction

11.5.4 Allergan Revenue in Irritable Bowel Syndrome Drug Business (2019-2024)

11.5.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Ironwood Pharmaceuticals

Bausch Health

Takeda

Sebela Pharmaceuticals

List of Tables

Table 1. Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of IBS-D Drugs

Table 3. Key Players of IBS-C Drugs

Table 4. Key Players of Others

Table 5. Global Irritable Bowel Syndrome Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Irritable Bowel Syndrome Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Irritable Bowel Syndrome Drug Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Irritable Bowel Syndrome Drug Market Share by Region (2019-2024)

Table 9. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Irritable Bowel Syndrome Drug Market Share by Region (2025-2030)

Table 11. Irritable Bowel Syndrome Drug Market Trends

Table 12. Irritable Bowel Syndrome Drug Market Drivers

Table 13. Irritable Bowel Syndrome Drug Market Challenges

Table 14. Irritable Bowel Syndrome Drug Market Restraints

Table 15. Global Irritable Bowel Syndrome Drug Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Irritable Bowel Syndrome Drug Market Share by Players (2019-2024)

Table 17. Global Top Irritable Bowel Syndrome Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Drug as of 2023)

Table 18. Ranking of Global Top Irritable Bowel Syndrome Drug Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome Drug Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Irritable Bowel Syndrome Drug Product Solution and Service

Table 22. Date of Enter into Irritable Bowel Syndrome Drug Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Irritable Bowel Syndrome Drug Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Irritable Bowel Syndrome Drug Revenue Market Share by Type (2019-2024)

Table 26. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Irritable Bowel Syndrome Drug Revenue Market Share by Type (2025-2030)

Table 28. Global Irritable Bowel Syndrome Drug Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Irritable Bowel Syndrome Drug Revenue Market Share by Application (2019-2024)

Table 30. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Irritable Bowel Syndrome Drug Revenue Market Share by Application (2025-2030)

Table 32. North America Irritable Bowel Syndrome Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Irritable Bowel Syndrome Drug Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Irritable Bowel Syndrome Drug Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Irritable Bowel Syndrome Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Irritable Bowel Syndrome Drug Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Irritable Bowel Syndrome Drug Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Irritable Bowel Syndrome Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Irritable Bowel Syndrome Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Irritable Bowel Syndrome Drug Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Irritable Bowel Syndrome Drug Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Irritable Bowel Syndrome Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2025-2030) & (US$ Million)

Table 47. Ironwood Pharmaceuticals Company Detail

Table 48. Ironwood Pharmaceuticals Business Overview

Table 49. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product

Table 50. Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2019-2024) & (US$ Million)

Table 51. Ironwood Pharmaceuticals Recent Development

Table 52. Bausch Health Company Detail

Table 53. Bausch Health Business Overview

Table 54. Bausch Health Irritable Bowel Syndrome Drug Product

Table 55. Bausch Health Revenue in Irritable Bowel Syndrome Drug Business (2019-2024) & (US$ Million)

Table 56. Bausch Health Recent Development

Table 57. Takeda Company Detail

Table 58. Takeda Business Overview

Table 59. Takeda Irritable Bowel Syndrome Drug Product

Table 60. Takeda Revenue in Irritable Bowel Syndrome Drug Business (2019-2024) & (US$ Million)

Table 61. Takeda Recent Development

Table 62. Sebela Pharmaceuticals Company Detail

Table 63. Sebela Pharmaceuticals Business Overview

Table 64. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product

Table 65. Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2019-2024) & (US$ Million)

Table 66. Sebela Pharmaceuticals Recent Development

Table 67. Allergan Company Detail

Table 68. Allergan Business Overview

Table 69. Allergan Irritable Bowel Syndrome Drug Product

Table 70. Allergan Revenue in Irritable Bowel Syndrome Drug Business (2019-2024) & (US$ Million)

Table 71. Allergan Recent Development

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Irritable Bowel Syndrome Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Irritable Bowel Syndrome Drug Market Share by Type: 2023 VS 2030

Figure 3. IBS-D Drugs Features

Figure 4. IBS-C Drugs Features

Figure 5. Others Features

Figure 6. Global Irritable Bowel Syndrome Drug Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Irritable Bowel Syndrome Drug Market Share by Application: 2023 VS 2030

Figure 8. Women Case Studies

Figure 9. Men Case Studies

Figure 10. Irritable Bowel Syndrome Drug Report Years Considered

Figure 11. Global Irritable Bowel Syndrome Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Irritable Bowel Syndrome Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Irritable Bowel Syndrome Drug Market Share by Region: 2023 VS 2030

Figure 14. Global Irritable Bowel Syndrome Drug Market Share by Players in 2023

Figure 15. Global Top Irritable Bowel Syndrome Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Drug as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome Drug Revenue in 2023

Figure 17. North America Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Irritable Bowel Syndrome Drug Market Share by Country (2019-2030)

Figure 19. United States Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Irritable Bowel Syndrome Drug Market Share by Country (2019-2030)

Figure 23. Germany Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Irritable Bowel Syndrome Drug Market Share by Region (2019-2030)

Figure 31. China Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Irritable Bowel Syndrome Drug Market Share by Country (2019-2030)

Figure 39. Mexico Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Irritable Bowel Syndrome Drug Market Share by Country (2019-2030)

Figure 43. Turkey Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Irritable Bowel Syndrome Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Ironwood Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2019-2024)

Figure 46. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2019-2024)

Figure 47. Takeda Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2019-2024)

Figure 48. Sebela Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2019-2024)

Figure 49. Allergan Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2019-2024)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions